However, certain circumstances may prompt a provider to recommend more frequent monitoring or reassessment: Patients on liraglutide (Saxenda) may still require daily injections due to the drugs pharmacokinetics
Parker VER, Robertson D, Wang T et al (2020) Efficacy, safety, and mechanistic insights of cotadutide, a dual receptor glucagon-like peptide-1 and glucagon agonist
I wasnt expecting a dramatic overnight change
To protect muscle during treatment: Encourage strength training and physical activity Ensure adequate protein intake Use tools to monitor body composition, not just weight This helps patients maintain functionality while still achieving the metabolic benefits of treatment
Thus, a deficiency of GLP-1 is now considered as part of the pathophysiology of type 2 diabetes 1
Komatsu R, Matsuyama T, Namba M, Watanabe N, Itoh H, Kono N, Tarui S